UBS analyst Joshua Chan raised the firm’s price target on ABM (ABM) to $55 from $54 and keeps a Buy rating on the shares. Margin weakness in Q3 outweighs several positives, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABM:
